Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Y. Maruyama, J.M. Feola & C. Magura. (1984) Radiosensitivity of C. Parvum-stimulated Spleen to Acute 60Co and Low Dose Rate 137Cs and 252Cf Irradiation. International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine 46:6, pages 779-785.
Read now
Read now
Articles from other publishers (28)
Arghya Chattaraj & T Palani Selvam. (2023)
Microdosimetry-based investigation of biological effectiveness of
252
Cf brachytherapy source: TOPAS Monte Carlo study
. Physics in Medicine & Biology 68:22, pages 225005.
Crossref
Crossref
Shen Qian, Ling Ye, Yun-Hong Tian, Li-Gen Wang, Zuo-Ping Huang, Feng Li, Bing Hou, Ni Song, Juan Chen, Ying Liu, Xiao Liu & Tao Zhou. (2017) Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study. Chinese Journal of Cancer 36:1.
Crossref
Crossref
Xin Lei, Cheng-Yuan Qian, Yi Qing, Ke-Wei Zhao, Zheng-Zhou Yang, Nan Dai, Zhao-Yang Zhong, Cheng Tang, Zheng Li, Xian-Qing Gu, Qian Zhou, Yan Feng, Yan-Li Xiong, Jin-Lu Shan & Dong Wang. (2011) Californium-252 Brachytherapy Combined With External-Beam Radiotherapy for Cervical Cancer: Long-Term Treatment Results. International Journal of Radiation Oncology*Biology*Physics 81:5, pages 1264-1270.
Crossref
Crossref
R A Patchell, R J Yaes, L Beach, R J Kryscio, D G Davis, P A Tibbs & B Young. (1997) A phase I trial of neutron brachytherapy for the treatment of malignant gliomas.. The British Journal of Radiology 70:839, pages 1162-1168.
Crossref
Crossref
T. Tačev, B. Ptáčková, A. Vacek, O. Rašovská & V. Strnad. 1997. Californium-252 Isotope for 21st Century Radiotherapy. Californium-252 Isotope for 21st Century Radiotherapy
83
97
.
T. Tačev, A. Vacek, B. Prokes, O. Rašovská, B. Ptáčková, V. Strnad & V. Krystof. 1997. Californium-252 Isotope for 21st Century Radiotherapy. Californium-252 Isotope for 21st Century Radiotherapy
57
75
.
A. Miller, E. Atkocine, M. Kersuliene & V. Atkocius. 1997. Californium-252 Isotope for 21st Century Radiotherapy. Californium-252 Isotope for 21st Century Radiotherapy
211
219
.
YOSH MARUYAMA. 1992. Relative Radiation Sensitivities of Human Organ Systems, Part III. Relative Radiation Sensitivities of Human Organ Systems, Part III
71
152
.
Yosh Maruyama & Jacek Wierzbicki. (1990) Evaluation of time-dose and fractionation for 252Cf neutrons in preoperative bulky/barrel-cervix carcinoma radiotherapy. International Journal of Radiation Oncology*Biology*Physics 19:6, pages 1561-1568.
Crossref
Crossref
Yosh Maruyama, Jacek Wierzbicki, Jose Feola & Muneyasu Urano. (1990) Regeneration in cervic cancer after 252Cf neutron brachytherapy. International Journal of Radiation Oncology*Biology*Physics 19:1, pages 61-67.
Crossref
Crossref
Yosh Maruyama, Jose M. Feola, Jacek Wierzbicki, John R. van Nagell, Deborah Powell & Justine Yoneda. (1990)
Clinical study of relative biological effectiveness for cervical carcinoma treated by
252
Cf neutrons and assessed by histological tumour eradication
. The British Journal of Radiology 63:748, pages 270-277.
Crossref
Crossref
YOSH MARUYAMA. 1990. Relative Radiation Sensitivities of Human Organ Systems, Part II. Relative Radiation Sensitivities of Human Organ Systems, Part II
23
110
.
Yosh Maruyama. (1988) Neutron brachytherapy for the treatment of malignant neoplasia. International Journal of Radiation Oncology*Biology*Physics 15:6, pages 1415-1429.
Crossref
Crossref
Yosh Maruyama, Nabil B. Darwazeh & Clara Magura. (1988)
Increased
252
Cf therapeutic advantage for an advanced murine lymphoma (LSA) growing
in vivo
. The British Journal of Radiology 61:724, pages 312-316.
Crossref
Crossref
Yosh Maruyama, John R. van Nagell, Jose M. Feola, J.Lawrence Beach, Justine Yoneda, Elvis Donaldson, Holly Gallion, Ken Rowley & Deborah Powell. (1987) Specimen histology after one or two preoperative CF-252 implants for bulky stage IB cervical cancer. International Journal of Radiation Oncology*Biology*Physics 13:10, pages 1473-1478.
Crossref
Crossref
Yosh Maruyama, John R. Vannagell, Justine Yoneda, Elvis Donaldson, Holly Gallion, Ken Rowley, Richard Kryscio & Joseph L. Beach. (1987) Phase I-II clinical trial of californium-252. Treatment of stage IB carcinoma of the cervix. Cancer 59:8, pages 1500-1505.
Crossref
Crossref
YOSH MARUYAMA & JOSE M. FEOLA. 1987. Relative Radiation Sensitivities of Human Organ Systems. Relative Radiation Sensitivities of Human Organ Systems
1
82
.
Y. Maruyama & J.L. Beach. (1986) CF-252 Neutron brachytherapy of short duration for bulky neck tumors. International Journal of Radiation Oncology*Biology*Physics 12:5, pages 761-770.
Crossref
Crossref
Y. Maruyama, J.M. Feola, C. Magura, C.I. Onomura & J.L. Beach. (1985) Study of acute 60Co, low dose rate CF-252 and CS-137 radiation on LSA ascites lymphoma In Vivo. International Journal of Radiation Oncology*Biology*Physics 11:11, pages 1991-1997.
Crossref
Crossref
Y. Maruyama, R. Kryscio, J.R. Van Nagell, J. Yoneda, E. Donaldson, M. Hanson, J.L. Beach, J.M. Feola, A. Martin & C. Parker. (1985) Clinical trial of 252Cf neutron brachytherapy vs. conventional radiotherapy for advanced cervical cancer. International Journal of Radiation Oncology*Biology*Physics 11:8, pages 1475-1482.
Crossref
Crossref
Y Maruyama, J.R.Van Nagell, E Donaldson, J.L Beach, A Martin, R Kryscio, J Yoneda, M Hanson, J.M Feola & C Parker. (1985) NEUTRON BRACHYTHERAPY IS BETTER THAN CONVENTIONAL RADIOTHERAPY IN ADVANCED CERVICAL CANCER. The Lancet 325:8438, pages 1120-1122.
Crossref
Crossref
Yosh Maruyama, J. Lawrence Beach, John Hazle, Manzar Ashtari, Carter B. Schroy & Marvin H. Olson. (1985) Therapeutic dosimetry for Cf-252 neutron brachytherapy of pelvic cancer. International Journal of Radiation Oncology*Biology*Physics 11:5, pages 927-935.
Crossref
Crossref
H.N. Hwang, J.M. Feola, J.L. Beach & Y. Maruyama. (1984) RBE of CF-252 neutrons by mouse testes weight loss. International Journal of Radiation Oncology*Biology*Physics 10:6, pages 901-905.
Crossref
Crossref
Y. Maruyama, J. M. Feola, H. N. Hwang, A. Williams & J. L. Beach. (1983) RBE of spleen CFU-S to low dose rate Cf-252 neutron or photon radiation. Radiation and Environmental Biophysics 21:4, pages 265-274.
Crossref
Crossref
Yosh Maruyama, Jose M. Feola & J.Lawrence Beach. (1983) A tumor/normal tissue advantage for low dose rate neutron brachytherapy. International Journal of Radiation Oncology*Biology*Physics 9:11, pages 1715-1721.
Crossref
Crossref
B. J. ALLEN. (2008) Neutron Therapy. Australasian Radiology 27:2, pages 195-214.
Crossref
Crossref
Yosh Maruyama, Chester Nava, Jose Feola, J.Lawrence Beach, Hung-Nien Hwang & Annie Williams. (1983) RBE of spleen CFU-S to low dose rate Cf-252 or photon radiation in vivo. International Journal of Radiation Oncology*Biology*Physics 9:7, pages 1049-1056.
Crossref
Crossref
James E. Chaney, Kunio Kobayashi, Rensuke Goto & George A. Digenis. (1983) Tumor selective enhancement of radioactivity uptake in mice treated with α-difluoromethylornithine prior to administration of 14C-putrescine. Life Sciences 32:11, pages 1237-1241.
Crossref
Crossref